Petersen E A, Neva F A, Barral A, Correa-Coronas R, Bogaert-Diaz H, Martinez D, Ward F E
J Immunol. 1984 May;132(5):2603-6.
Patients from the Dominican Republic with diffuse cutaneous leishmaniasis showed in vivo and in vitro anergy to leishmanial antigen. Relatives of these DCL patients living in the same endemic area frequently showed skin test and lymphocyte reactivity to leishmanial antigens. This further supports the concept of specific anergy in patients with diffuse cutaneous leishmaniasis. Adherent suppressor cells modulate the antigen-specific lymphocyte proliferative response. Suppressor cells could also be isolated by Percoll gradient centrifugation. Co-culturing of lymphocytes and monocytes from HLA-identical leishmanin responders and nonresponders also identified the suppressor cell as a monocyte. In one patient, this suppression disappeared when clinical cure had been accomplished.
来自多米尼加共和国的弥漫性皮肤利什曼病患者在体内和体外对利什曼原虫抗原均表现出无反应性。生活在同一流行地区的这些弥漫性皮肤利什曼病患者的亲属经常表现出对利什曼原虫抗原的皮肤试验和淋巴细胞反应性。这进一步支持了弥漫性皮肤利什曼病患者存在特异性无反应性的概念。黏附性抑制细胞调节抗原特异性淋巴细胞增殖反应。抑制细胞也可通过Percoll梯度离心分离。对来自 HLA 相同的利什曼菌素反应者和无反应者的淋巴细胞和单核细胞进行共培养,也确定抑制细胞为单核细胞。在一名患者中,当临床治愈完成时,这种抑制作用消失。